Invesco Ltd. bought a new position in Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 105,783 shares of the technology company's stock, valued at approximately $6,545,000. Invesco Ltd. owned 3.68% of Kewaunee Scientific at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wedbush Securities Inc. purchased a new position in shares of Kewaunee Scientific during the 4th quarter valued at $262,000. O Shaughnessy Asset Management LLC lifted its position in shares of Kewaunee Scientific by 3.3% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company's stock worth $1,733,000 after purchasing an additional 891 shares during the last quarter. American Century Companies Inc. boosted its position in shares of Kewaunee Scientific by 18.0% in the fourth quarter. American Century Companies Inc. now owns 34,293 shares of the technology company's stock valued at $2,122,000 after acquiring an additional 5,221 shares during the period. Truffle Hound Capital LLC bought a new stake in Kewaunee Scientific in the 4th quarter valued at $619,000. Finally, Morgan Dempsey Capital Management LLC acquired a new stake in Kewaunee Scientific during the fourth quarter worth about $106,000. 32.69% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, StockNews.com lowered shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a report on Friday, March 14th.
View Our Latest Analysis on KEQU
Kewaunee Scientific Price Performance
Shares of KEQU traded up $0.07 during trading hours on Thursday, hitting $31.74. The stock had a trading volume of 1,904 shares, compared to its average volume of 24,068. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The stock has a market capitalization of $90.60 million, a price-to-earnings ratio of 5.05 and a beta of 0.59. Kewaunee Scientific Co. has a 52 week low of $30.33 and a 52 week high of $71.33. The company's fifty day moving average is $41.76 and its two-hundred day moving average is $47.31.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The business had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.
Insider Activity
In other news, CFO Donald T. Gardner III sold 3,000 shares of the business's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $40.01, for a total value of $120,030.00. Following the sale, the chief financial officer now owns 18,358 shares of the company's stock, valued at $734,503.58. The trade was a 14.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Thomas David Hull III sold 1,844 shares of the firm's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $32.44, for a total value of $59,819.36. Following the completion of the transaction, the chief executive officer now owns 36,072 shares of the company's stock, valued at $1,170,175.68. The trade was a 4.86 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 11,057 shares of company stock valued at $440,326. 14.20% of the stock is currently owned by insiders.
Kewaunee Scientific Profile
(
Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories

Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.